Dyne Therapeutics (DYN)'s 30-day implied volatility (IV30) was 49.9% at the close on November 12, 2026, up from 47.6% the day before, against a 52-week range of 37.9% to 112.7%. Its 20-day historical volatility was 61.5%.
Data as of November 12, 2026.